243 related articles for article (PubMed ID: 34918396)
1. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
2. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
[TBL] [Abstract][Full Text] [Related]
3. H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression.
Saeidi S; Kim SJ; Han HJ; Kim SH; Zheng J; Lee HB; Han W; Noh DY; Na HK; Surh YJ
Toxicol Appl Pharmacol; 2020 Sep; 402():115121. PubMed ID: 32621833
[TBL] [Abstract][Full Text] [Related]
4. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
[TBL] [Abstract][Full Text] [Related]
5. The Peptidyl-Prolyl
Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
[TBL] [Abstract][Full Text] [Related]
6. Dual Roles of Pin1 in Cancer Development and Progression.
Han HJ; Choi BY; Surh YJ
Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
[TBL] [Abstract][Full Text] [Related]
7. The peptidyl prolyl isomerase, PIN1 induces angiogenesis through direct interaction with HIF-2α.
Choi MA; Saeidi S; Han HJ; Kim SJ; Kwon N; Kim DH; Min SH; Choi BY; Surh YJ
Biochem Biophys Res Commun; 2020 Dec; 533(4):995-1003. PubMed ID: 33012513
[TBL] [Abstract][Full Text] [Related]
8. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.
Kim G; Bhattarai PY; Choi HS
Arch Pharm Res; 2019 Feb; 42(2):128-139. PubMed ID: 30684192
[TBL] [Abstract][Full Text] [Related]
9. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
[TBL] [Abstract][Full Text] [Related]
10. Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.
Chen XR; Igumenova TI
Adv Biol Regul; 2023 Jan; 87():100938. PubMed ID: 36496344
[TBL] [Abstract][Full Text] [Related]
11. A critical step for JNK activation: isomerization by the prolyl isomerase Pin1.
Park JE; Lee JA; Park SG; Lee DH; Kim SJ; Kim HJ; Uchida C; Uchida T; Park BC; Cho S
Cell Death Differ; 2012 Jan; 19(1):153-61. PubMed ID: 21660049
[TBL] [Abstract][Full Text] [Related]
12. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation.
Liao Y; Wei Y; Zhou X; Yang JY; Dai C; Chen YJ; Agarwal NK; Sarbassov D; Shi D; Yu D; Hung MC
Oncogene; 2009 Jul; 28(26):2436-45. PubMed ID: 19448664
[TBL] [Abstract][Full Text] [Related]
14. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
15. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
16. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
17. Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer.
Nicole Tsang YH; Wu XW; Lim JS; Wee Ong C; Salto-Tellez M; Ito K; Ito Y; Chen LF
Oncogene; 2013 Mar; 32(12):1488-96. PubMed ID: 22580604
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α.
Han HJ; Kwon N; Choi MA; Jung KO; Piao JY; Ngo HK; Kim SJ; Kim DH; Chung JK; Cha YN; Youn H; Choi BY; Min SH; Surh YJ
PLoS One; 2016; 11(1):e0147038. PubMed ID: 26784107
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells.
Samanta SK; Lee J; Hahm ER; Singh SV
Mol Carcinog; 2018 Jul; 57(7):936-946. PubMed ID: 29603395
[TBL] [Abstract][Full Text] [Related]
20. Interaction between Peptidyl-prolyl
Saeidi S; Joo S; Kim SJ; Jagadeesh ASV; Surh YJ
J Cancer Prev; 2020 Dec; 25(4):234-243. PubMed ID: 33409256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
